Table 3

Associations between CLDQ and SF-36 domains in patients with NASH

CLDQ SF-36	AS	FA	SS	AC	EF	WO	Total
PF	0.48	0.60	0.62	0.61	0.46	0.55	0.66
RP	0.49	0.75	0.52	0.60	0.55	0.67	0.70
BP	0.73	0.72	0.81	0.71	0.53	0.57	0.80
GH	0.51	0.70	0.59	0.59	0.57	0.65	0.70
VT	0.41	0.81	0.47	0.53	0.59	0.48	0.64
SF	0.45	0.69	0.42	0.57	0.72	0.64	0.67
RE	0.35	0.38	0.35	0.46	0.59	0.44	0.51
MH	0.24	0.41	0.18	0.35	0.76	0.46	0.46
PCS	0.61	0.78	0.73	0.66	0.46	0.62	0.76
MCS	0.38	0.54	0.28	0.44	0.82	0.48	0.56

AC, activity; AS, abdominal symptoms; BP, body pain; CLDQ, Chronic Liver Disease Questionnaire; EF, emotional function; FA, fatigue; GH, general health; NASH, non-alcoholic steatohepatitis; MH, mental health; PF, physical functioning; RE, role emotional; RP, role physical; SF, social function; SF-36, Short-Form 36; SS, systemic symptoms; VT, vitality; WO, worry.